| Project/Area Number |
20830094
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (Start-up)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Business administration
|
|---|
| Research Institution | Tokyo University of Science |
|---|
Principal Investigator |
ISHIHARA Masahiko Tokyo University of Science, 大学院・総合科学技術経営研究科, 助教 (60510047)
|
|---|
| Project Period (FY) |
2008 – 2009
|
| Project Status |
Completed (Fiscal Year 2009)
|
| Budget Amount *help |
¥2,041,000 (Direct Cost: ¥1,570,000、Indirect Cost: ¥471,000)
Fiscal Year 2009: ¥728,000 (Direct Cost: ¥560,000、Indirect Cost: ¥168,000)
Fiscal Year 2008: ¥1,313,000 (Direct Cost: ¥1,010,000、Indirect Cost: ¥303,000)
|
|---|
| Keywords | 技術経営 / MOT / イノベーション・プロセス / 医薬品開発 / バイオテクノロジー / 中核技術 / コア技術 / 市場規模予測 / イノベーション / 新薬開発 / エリスロポイエチン / スタチン / インターフェロン |
|---|
| Research Abstract |
In this study, I examined the mechanism of the recognition process of new information for discovery or invention at the early stage of innovation in pharmaceutical industry, and tried to reveal the nature of the problems at the early stage of the innovation. As a result, I have introduced following two hypotheses. 1) The logic of the organisms in the company and/or the gap of information volume between the Information for the effects of the medicine candidates in human body and the knowledge of the human for that information, may affect the accuracy of estimation for the market size of the candidates. 2) The feature of the core technology and/or the difficulties of the recognition process of the core technology may cause the company to recognize the own core technologies.
|
